OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Structural Studies of GABAA Receptor Binding Sites: Which Experimental Structure Tells us What?
Roshan Puthenkalam, Marcel Hieckel, Xenia Simeone, et al.
Frontiers in Molecular Neuroscience (2016) Vol. 9
Open Access | Times Cited: 86

Showing 1-25 of 86 citing articles:

GABAA receptor: Positive and negative allosteric modulators
Richard W. Olsen
Neuropharmacology (2018) Vol. 136, pp. 10-22
Open Access | Times Cited: 301

The Benzodiazepine Binding Sites of GABAA Receptors
Erwin Sigel, Margot Ernst
Trends in Pharmacological Sciences (2018) Vol. 39, Iss. 7, pp. 659-671
Closed Access | Times Cited: 226

International Union of Basic and Clinical Pharmacology. CVI: GABAAReceptor Subtype- and Function-selective Ligands: Key Issues in Translation to Humans
Werner Sieghart, Miroslav M. Savić
Pharmacological Reviews (2018) Vol. 70, Iss. 4, pp. 836-878
Open Access | Times Cited: 179

THC and CBD: Similarities and differences between siblings
Nephi Stella
Neuron (2023) Vol. 111, Iss. 3, pp. 302-327
Open Access | Times Cited: 57

GABA‐modulating phytomedicines for anxiety: A systematic review of preclinical and clinical evidence
Karen Savage, Joseph Firth, Con Stough, et al.
Phytotherapy Research (2017) Vol. 32, Iss. 1, pp. 3-18
Open Access | Times Cited: 111

The ups and downs of alkyl‐carbamates in epilepsy therapy: How does cenobamate differ?
Wolfgang Löscher, Graeme J. Sills, H. Steve White
Epilepsia (2021) Vol. 62, Iss. 3, pp. 596-614
Open Access | Times Cited: 56

Mechanisms of inhibition and activation of extrasynaptic αβ GABAA receptors
Vikram Babu Kasaragod, Martin Mortensen, Steven W. Hardwick, et al.
Nature (2022) Vol. 602, Iss. 7897, pp. 529-533
Open Access | Times Cited: 50

Imidazopyridine-based selective and multifunctional ligands of biological targets associated with psychiatric and neurodegenerative diseases
David Vanda, Paweł Zajdel, Miroslav Soural
European Journal of Medicinal Chemistry (2019) Vol. 181, pp. 111569-111569
Closed Access | Times Cited: 75

GABA Receptors and the Pharmacology of Sleep
William Wisden, Xiao Yu, Nicholas P. Franks
Handbook of experimental pharmacology (2017), pp. 279-304
Closed Access | Times Cited: 67

Endozepines and their receptors: Structure, functions and pathophysiological significance
Marie‐Christine Tonon, Hubert Vaudry, Julien Chuquet, et al.
Pharmacology & Therapeutics (2019) Vol. 208, pp. 107386-107386
Open Access | Times Cited: 63

Elephants in the Dark: Insights and Incongruities in Pentameric Ligand-gated Ion Channel Models
Rebecca J. Howard
Journal of Molecular Biology (2021) Vol. 433, Iss. 17, pp. 167128-167128
Open Access | Times Cited: 39

α6-Containing GABAAReceptors: Functional Roles and Therapeutic Potentials
Werner Sieghart, Lih‐Chu Chiou, Margot Ernst, et al.
Pharmacological Reviews (2022) Vol. 74, Iss. 1, pp. 238-270
Open Access | Times Cited: 25

α subunits in GABAA receptors are dispensable for GABA and diazepam action
Nisa Wongsamitkul, María C. Maldifassi, Xenia Simeone, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 42

Suppressed oligodendrocyte steroidogenesis in multiple sclerosis: Implications for regulation of neuroinflammation
Roobina Boghozian, Brienne McKenzie, Leina B. Saito, et al.
Glia (2017) Vol. 65, Iss. 10, pp. 1590-1606
Closed Access | Times Cited: 40

Natural product modulators of human sensations and mood: molecular mechanisms and therapeutic potential
Tomáš Pluskal, Jing‐Ke Weng
Chemical Society Reviews (2017) Vol. 47, Iss. 5, pp. 1592-1637
Closed Access | Times Cited: 40

Molecular mechanisms of the GABA type A receptor function
Michał A. Michałowski, Karol Kłopotowski, Grzegorz Wiera, et al.
Quarterly Reviews of Biophysics (2025) Vol. 58
Closed Access

Different Benzodiazepines Bind with Distinct Binding Modes to GABAA Receptors
Alshaimaa A. Elgarf, David Chan Bodin Siebert, Friederike Steudle, et al.
ACS Chemical Biology (2018) Vol. 13, Iss. 8, pp. 2033-2039
Open Access | Times Cited: 35

Quercetin Reduces Cortical GABAergic Transmission and Alleviates MK-801-Induced Hyperactivity
Hui-Ran Fan, Weifeng Du, Tao Zhu, et al.
EBioMedicine (2018) Vol. 34, pp. 201-213
Open Access | Times Cited: 34

Phenols and GABAA receptors: from structure and molecular mechanisms action to neuropsychiatric sequelae
С. А. Мензиков, Danila M. Zaichenko, Aleksey A. Moskovtsev, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3

Synthesis and physicochemical evaluation of tetrafluorinated GABA analogue
Danylo Marych, Vitaliy A. Bilenko, Yaryna V. Ilchuk, et al.
Journal of Fluorine Chemistry (2024) Vol. 277, pp. 110307-110307
Closed Access | Times Cited: 3

The α5-Containing GABAA Receptors—a Brief Summary
Fatin H. Mohamad, Ahmad Tarmizi Che Has
Journal of Molecular Neuroscience (2019) Vol. 67, Iss. 2, pp. 343-351
Closed Access | Times Cited: 29

Allosteric GABAA Receptor Modulators—A Review on the Most Recent Heterocyclic Chemotypes and Their Synthetic Accessibility
Blanca Angelica Vega Alanis, Maria Teresa Iorio, Luca Silva, et al.
Molecules (2020) Vol. 25, Iss. 4, pp. 999-999
Open Access | Times Cited: 27

A novel de novo variant of GABRA1 causes increased sensitivity for GABA in vitro
Friederike Steudle, Sabah Rehman, Konstantina Bampali, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 24

Towards functional selectivity for α6β3γ2 GABAA receptors: a series of novel pyrazoloquinolinones
Marco Treven, David Chan Bodin Siebert, Raphael Holzinger, et al.
British Journal of Pharmacology (2017) Vol. 175, Iss. 3, pp. 419-428
Open Access | Times Cited: 26

Page 1 - Next Page

Scroll to top